Structural enzymology of sulphur metabolism in Mycobacterium tuberculosis

Biochemical and Biophysical Research Communications

Volumn 396, Issue 1, 2010, Pages 33-38

  Schnell, Robert ^a   Schneider, Gunter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cysteine biosynthesis; Enzyme structure; Enzymology; Inhibition; Tuberculosis

Indexed keywords

CYSTEINE; CYSTEINE SYNTHASE; PROTEIN CYSK1; PROTEIN NIRA; SULFITE REDUCTASE; SULFUR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL METABOLISM; BIOSYNTHESIS; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STEREOSPECIFICITY;

CYSTEINE; CYSTEINE SYNTHASE; FERREDOXIN-NITRITE REDUCTASE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN CONFORMATION; SERINE O-ACETYLTRANSFERASE; SULFUR;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77952310116     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.118     Document Type: Article

References (40)

1. Bloom B.R., and McKinney R.D. The death and resurrection of tuberculosis. Nat. Med. 5 (1999) 872-874
2. Wayne L.G., and Sramek H.A. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38 (1994) 807-811
3. Wallis R.S., Patil S., Cheon S.H., Edmonds K., Phillips M., Perkins M.D., Joloba M., Namale A., Johnson J.L., Teixeira L., Dietze R., Siddiqi S., Mugerwa R.D., Eisenach K K., and Ellner J.J. Drug tolerance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43 (1999) 2600-2666
4. Frieden T.R., and Munsiff S.S. The DOTS strategy for controlling the global tuberculosis epidemic. Clin. Chest Med. 26 (2005) 197-205
5. Wayne L.G., and Sohaskey C.D. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55 (2001) 139-163
6. McKinney J.D., Bentrup K., Munoz-Elias E.J., Miczak A., Chen B., Chan W.T., Swenson D., Sacchettini J.C., Jacobs Jr. W.R., and Russell D.G. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406 (2000) 735-738
7. Rhee K.Y., Erdjument-Bromage H., Tempst P., and Nathan C.F. S-nitroso proteome of Mycobacterium tuberculosis: enzymes of intermediary metabolism and antioxidant defense. Proc. Natl. Acad. Sci. USA 102 (2005) 467-472
8. Bornemann C., Jardine M.A., Spies H.S., and Steenkamp D.J. Biosynthesis of mycothiol: elucidation of the sequence of steps in Mycobacterium smegmatis. Biochem. J. 325 (1997) 623-629
9. Hu Y., and Coates A.R.M. Increased levels of sigJ mRNA in late stationary phase cultures of Mycobacterium tuberculosis detected by DNA array hybridisation. FEMS Microbiol. Lett. 202 (2001) 59-65
10. Schnappinger D., Ehrt S., Voskuil M.L., Liu Y., Mangan J.A., Monahan I.M., Dolganov G., Efron B., Butcher P.D., Nathan C., and Schoolnik G.K. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198 (2003) 693-704
11. Hampshire T., Soneji S., Bacon J., James B.W., Hinds J., Laing K., Stabler R.A., Marsh P.D., and Butcher P.D. Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?. Tuberculosis 84 (2004) 228-238
12. Starck J., Källenius G., Marklund B.I., Andersson D.I., and Akerlund T. Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. Microbiology 150 (2004) 3821-3829
13. Senaratne R.H., De Silva A.D., Williams S.J., Mougous J.D., Reader J.R., Zhang T., Chan S., Sidders B., Lee D.H., Chan J., Bertozzi C.R., and Riley L.W. 5′-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice. Mol. Microbiol. 59 (2006) 1744-1753
14. Voskuil M.L., Schnappinger D., Visconti K.C., Harrell M.I., Dolganov G.M., Sherman D.R., and Schoolnik G.K. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198 (2003) 705-713
15. Bhave D.P., Muse W.B., and Carroll K.S. Drug targets in mycobacterial sulfur metabolism. Infect. Disord. Drug Targets 7 (2007) 140-158
16. Williams S.J., Senaratne R.H., Mougous J.D., Riley L.W., and Bertozzi C.R. 5′-Adenosinephosphosulfate lies at a metabolic branch point in mycobacteria. J. Biol. Chem. 277 (2002) 32606-32615
17. Rengarajan J., Bloom B.R., and Rubin E.J. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc. Natl. Acad. Sci. USA 102 (2005) 8327-8332
18. Sassetti C.M., and Rubin E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100 (2003) 12989-12994
19. Schnell R., Ågren D., and Schneider G. 1.9 A structure of the signal receiver domain of the putative response regulator NarL from Mycobacterium tuberculosis. Acta Crystallogr. F 64 (2008) 1096-1100
20. Ågren D., Stehr M., Berthold C.L., Kapoor S., Oehlmann W., Singh M., and Schneider G. Three-dimensional structures of apo- and holo-l-alanine dehydrogenase from Mycobacterium tuberculosis reveal conformational changes upon coenzyme binding. J. Mol. Biol. 377 (2008) 1161-1173
21. Hutter B., and Singh M. Properties of the 40 kDa antigen of Mycobacterium tuberculosis, a functional l-alanine dehydrogenase. Biochem. J. 343 (1999) 669-672
22. Schnell R., Sandalova T., Hellman U., Lindqvist Y., and Schneider G. Siroheme- and [Fe4-S4]-dependent NirA from Mycobacterium tuberculosis is a sulfite reductase with a covalent Cys-Tyr bond in the active site. J. Biol. Chem. 280 (2005) 27319-27328
23. O'Leary S.E., Jurgenson C.T., Ealick S.E., and Begley T.P. O-phospho-l-serine and the thiocarboxylated sulfur carrier protein CysO-COSH are substrates for CysM, a cysteine synthase from Mycobacterium tuberculosis. Biochemistry 47 (2008) 11606-11615
24. Ågren D., Schnell R., Oehlmann W., Singh M., and Schneider G. Cysteine synthase (CYSM) of Mycobacterium tuberculosis is an O-phosphoserine sulfhydrylase: evidence for an alternative cysteine biosynthesis pathway in mycobacteria. J. Biol. Chem. 283 (2008) 31567-31574
25. Ågren D., Schnell R., and Schneider G. The C-terminal of CysM from Mycobacterium tuberculosis protects the aminoacrylate intermediate and is involved in sulfur donor selectivity. FEBS Lett. 583 (2009) 330-336
26. Rabeh W.M., and Cook P.F. Structure and mechanism of O-acetylserine sulfhydrylase. J. Biol. Chem. 279 (2004) 26803-26806
27. Schnell R., Oehlmann W., Singh M., and Schneider G. Structural insights into catalysis and inhibition of O-acetylserine sulfhydrylase from Mycobacterium tuberculosis. Crystal structures of the enzyme alpha-aminoacrylate intermediate and an enzyme-inhibitor complex. J. Biol. Chem. 282 (2007) 23473-23481
28. Carroll K.S., Gao H., Chen H., Stout C.D., Leary J.A., and Bertozzi C.R. A conserved mechanism for sulfonucleotide reduction. PLoS Biol. 3 (2005) e250
29. Burns K.E., Baumgart S., Dorrestein P.C., Zhai H., McLafferty F.W., and Begley T.P. Reconstitution of a new cysteine biosynthetic pathway in Mycobacterium tuberculosis. J. Am. Chem. Soc. 127 (2005) 11602-11603
30. Crane B.R., and Getzoff E.D. The relationship between structure and function for the sulfite reductases. Curr. Opin. Struct. Biol. 6 (1996) 744-756
31. Zeghouf M., Fontecave M., and Coves J. A simplified functional version of the Escherichia coli sulfite reductase. J. Biol. Chem. 275 (2000) 37651-37656
32. Knaff D.B., and Hirasawa M. Ferredoxin-dependent chloroplast enzymes. Biochim. Biophys. Acta 1056 (1991) 93-125
33. Crane B.R., Siegel L.M., and Getzoff E.D. Sulfite reductase structure at 1.6 Å: evolution and catalysis for reduction of inorganic anions. Science 270 (1995) 59-67
34. Pinto R., Harrison J.S., Hsu T., Jacobs W.R., and Leyh T.S. Sulfite reduction in mycobacteria. J. Bacteriol. 189 (2007) 6714-6722
35. Maier T.H. Semisynthetic production of unnatural l-alpha-amino acids by metabolic engineering of the cysteine-biosynthetic pathway. Nat. Biotechnol. 21 (2003) 422-427
36. Burkhard P., Rao G.S., Hohenester E., Schnackerz K.D., Cook P.F., and Jansonius J.N. Three-dimensional structure of O-acetylserine sulfhydrylase from Salmonella typhimurium. J. Mol. Biol. 283 (1998) 121-133
37. Rege V.D., Kredich N.M., Tai C.H., Karsten W.E., Schnackerz K.D., and Cook P.F. A change in the internal aldimine lysine (K42) in O-acetylserine sulfhydrylase to alanine indicates its importance in transimination and as a general base catalyst. Biochemistry 35 (1996) 13485-13493
38. Huang B., Vetting M.W., and Roderick S.L. The active site of O-acetylserine sulfhydrylase is the anchor point for bienzyme complex formation with serine acetyltransferase. J. Bacteriol. 187 (2005) 3201-3205
39. Jurgenson C.T., Burns K.E., Begley T.P., and Ealick S.E. Crystal structure of a sulfur carrier protein complex found in the cysteine biosynthetic pathway of Mycobacterium tuberculosis. Biochemistry 47 (2008) 10354-10364
40. Mino K., and Ishikawa K. A novel O-phospho-l-serine sulfhydrylation reaction catalyzed by O-acetylserine sulfhydrylase from Aeropyrum pernix K1. FEBS Lett. 551 (2003) 133-138